M&A Deal Summary

IDOX Acquires Halarose Holdings

On August 17, 2017, IDOX acquired software company Halarose Holdings for 5M GBP

Acquisition Highlights
  • This is IDOX’s 6th transaction in the Software sector.
  • This is IDOX’s 4th largest (disclosed) transaction.
  • This is IDOX’s 12th transaction in the United Kingdom.

M&A Deal Summary

Date 2017-08-17
Target Halarose Holdings
Sector Software
Buyer(s) IDOX
Deal Type Add-on Acquisition
Deal Value 5M GBP

Target

Halarose Holdings

Woodcote, United Kingdom
Halarose Holdings Ltd. develops, markets, sells and supports a range of electoral back office software and services to UK local authorities. It enables its customers to be more efficient both in the production and management of the electoral register and in the running of elections and referenda. Halarose's 76 clients include some of the largest local authorities in the UK including Birmingham, Leeds, Lothian and Lanarkshire.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

IDOX

Woking, United Kingdom

Category Company
Founded 2000
Sector Software
Employees682
Revenue 88M GBP (2024)
DESCRIPTION

IDOX is a provider of document management and software solutions to the UK public sector and global asset-intensive industries. Idox was founded in 2000 and is based in Woking, England.


DEAL STATS #
Overall 19 of 19
Sector: Software M&A 6 of 6
Type: Add-on Acquisition M&A Deals 16 of 16
Country: United Kingdom M&A 12 of 12
Year: 2017 M&A 1 of 1
Size (of disclosed) 4 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-14 6pm Holdings

Birkirkara, Malta

6pm Holdings Plc is a provider of world class IT Health Solutions. Company develop major edge solutions to improve the patient's experience and keep the health service sustainable throughout the 21st century. Company core health products such as Climate-HIV, StrokePad™ and ConCERT-D are targeted at managing and treating diseases like stroke, HIV and dementia.

Buy £18M